Oncimmune Holdings Revenue vs. Earnings Per Share
| ONC Stock | 15.10 0.10 0.66% |
Total Revenue | First Reported 2013-01-31 | Previous Quarter 28 K | Current Value 1.2 M | Quarterly Volatility 534.8 K |
For Oncimmune Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Oncimmune Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Oncimmune Holdings plc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Oncimmune Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Oncimmune Holdings plc over time as well as its relative position and ranking within its peers.
Oncimmune |
Oncimmune Holdings plc Earnings Per Share vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Oncimmune Holdings's current stock value. Our valuation model uses many indicators to compare Oncimmune Holdings value to that of its competitors to determine the firm's financial worth. Oncimmune Holdings plc is rated top company in revenue category among its peers. It also is considered to be number one stock in earnings per share category among its peers . At present, Oncimmune Holdings' Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncimmune Holdings' earnings, one of the primary drivers of an investment's value.Oncimmune Revenue vs. Competition
Oncimmune Holdings plc is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 953.73 Billion. Oncimmune Holdings adds roughly 1.15 Million in revenue claiming only tiny portion of equities under Health Care industry.
Oncimmune Earnings Per Share vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Oncimmune Holdings |
| = | 1.15 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Oncimmune Holdings |
| = | (0.03) X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Oncimmune Earnings Per Share Comparison
Oncimmune Holdings is currently under evaluation in earnings per share category among its peers.
Oncimmune Holdings Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Oncimmune Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Oncimmune Holdings will eventually generate negative long term returns. The profitability progress is the general direction of Oncimmune Holdings' change in net profit over the period of time. It can combine multiple indicators of Oncimmune Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -256.4 K | -269.3 K | |
| Operating Income | -3.8 M | -4 M | |
| Income Before Tax | -5.3 M | -5.6 M | |
| Total Other Income Expense Net | -1.5 M | -1.4 M | |
| Net Loss | -5.5 M | -5.8 M | |
| Income Tax Expense | 200.7 K | 210.7 K | |
| Net Loss | -5.5 M | -5.8 M | |
| Net Loss | -8.6 M | -9 M | |
| Net Interest Income | -1.6 M | -1.5 M | |
| Change To Netincome | 2.7 M | 2.8 M |
Oncimmune Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Oncimmune Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Oncimmune Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Oncimmune Holdings' important profitability drivers and their relationship over time.
Use Oncimmune Holdings in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oncimmune Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncimmune Holdings will appreciate offsetting losses from the drop in the long position's value.Oncimmune Holdings Pair Trading
Oncimmune Holdings plc Pair Trading Analysis
The ability to find closely correlated positions to Oncimmune Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oncimmune Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oncimmune Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oncimmune Holdings plc to buy it.
The correlation of Oncimmune Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oncimmune Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oncimmune Holdings plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oncimmune Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Oncimmune Holdings position
In addition to having Oncimmune Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Railroads Thematic Idea Now
Railroads
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Oncimmune Stock
To fully project Oncimmune Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Oncimmune Holdings plc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Oncimmune Holdings' income statement, its balance sheet, and the statement of cash flows.